Verzenios ® ▼ (abemaciclib)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Verzenios Summary of Product Characteristics (SmPC)

Verzenios® ▼ (abemaciclib): Storage and Packaging

Verzenios (abemaciclib) does not require any special storage conditions.

Dosage Form

PCTFE/PE/PVC blisters sealed with an aluminium foil in a calendar blister card, in packs of 14, 28, 42, 56, 70 or 168 film-coated tablets.1

Aluminium/aluminium perforated unit dose blisters of 28 x 1 film-coated tablets.1

Not all pack sizes may be marketed.1

Table 1.  Abemaciclib qualitative and quantitative composition1

Verzenios 50 mg film-coated tablets

Beige, oval tablet of 5.2 x 9.5 mm, debossed with “Lilly” on one side and “50” on the other.

Verzenios 100 mg film-coated tablets

White, oval tablet of 6.6 x 12.0 mm, debossed with “Lilly” on one side and “100” on the other.

Verzenios 150 mg film-coated tablets

Yellow, oval tablet of 7.5 x 13.7 mm, debossed with “Lilly” on one side and “150” on the other.

Administration

Abemaciclib  is for oral use.1

Patients should take the doses at approximately the same times every day.

The tablet should be swallowed whole (patients should not chew, crush, or split tablets before swallowing).1

If a patient vomits or misses a dose of abemaciclib, the patient should be instructed to take the next dose at its scheduled time; an additional dose should not be taken.1

Storage

This medicinal product does not require any special storage conditions.1

Disposal

Any unused medicinal product or waste material should be disposed of in accordance with local requirements.1

References

1. Verzenios [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

Glossary

MSDS =  Material Safety Data Sheet

PCTFE = Polychlorotrifluoroethylene

PE = Polyethylene

PVC = Polyvinyl Chloride

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Date of Last Review: January 03, 2019

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 8am - 4pm, excluding Bank Holidays

Or you can

Ask us a question Chat with Us If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a question